PHI som gäst i Fill or Kill podcast: Avsnitt 366

Despite a summer-sluggish period ending in July, sales were just one unit away from surpassing our best quarter ever; the same period last year.

PHI visits the WFIRM to finalize an agreement concerning the automation of advanced quality control in large-scale biomanufacturing of regenerative therapies.

Sales more than doubled in 2021/22, compared to previous financial year.